<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05944756595654</udiDi>
    <basicUdiDi>B-05944756595654</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1722</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:57:04.737Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756595647</udiDi>
    <basicUdiDi>B-05944756595647</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1721</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:57:01.511Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756595593</udiDi>
    <basicUdiDi>B-05944756595593</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1716</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:56:52.705Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756595036</udiDi>
    <basicUdiDi>B-05944756595036</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1660</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:24.271Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756595029</udiDi>
    <basicUdiDi>B-05944756595029</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1659</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:23.474Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756595012</udiDi>
    <basicUdiDi>B-05944756595012</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1658</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:21.866Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756595005</udiDi>
    <basicUdiDi>B-05944756595005</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1657</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:19.468Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594992</udiDi>
    <basicUdiDi>B-05944756594992</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1656</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:17.864Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594985</udiDi>
    <basicUdiDi>B-05944756594985</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1655</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:17.082Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594978</udiDi>
    <basicUdiDi>B-05944756594978</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1654</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:15.668Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594961</udiDi>
    <basicUdiDi>B-05944756594961</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1653</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:13.058Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594954</udiDi>
    <basicUdiDi>B-05944756594954</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1652</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:12.095Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594947</udiDi>
    <basicUdiDi>B-05944756594947</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1651</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:12.060Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594930</udiDi>
    <basicUdiDi>B-05944756594930</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1650</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:10.133Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594923</udiDi>
    <basicUdiDi>B-05944756594923</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1649</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:06.670Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594916</udiDi>
    <basicUdiDi>B-05944756594916</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1648</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:05.060Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594909</udiDi>
    <basicUdiDi>B-05944756594909</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1647</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:04.253Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594893</udiDi>
    <basicUdiDi>B-05944756594893</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1646</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:02.667Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594886</udiDi>
    <basicUdiDi>B-05944756594886</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1645</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:53:00.247Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594879</udiDi>
    <basicUdiDi>B-05944756594879</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1644</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:52:58.649Z</lastUpdated>
  </row>
</eudamedExport>